Mechanism of the pathogenesis of myocarditis and cardiomyopathy due to hepatitis C virus
丙型肝炎病毒引起的心肌炎和心肌病的发病机制
基本信息
- 批准号:08457207
- 负责人:
- 金额:$ 5.38万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Anti-hepatitis C virus antibody was present in the sera of 8 of 53 patients (15.1%) with dilated cardiomyopathy and 11 of 66 patients (13.8%) with hypertrophic cardiomyopathy, versus 2.4% in control population of voluntary blood donors in Japan, a statistically significant difference (p<0.0001). In hypertrophic cardiomyopathy, type 1b hepatitis C virus RNA was present in the sera of 5 of the 9 patients. The copy number of hepatitis C virus was 5.5x10^3to8.6x10^5 genomes/ml serum, and multiple clones of hepatitis C virus were detected in the sera of each patient. Positive strands of hepatitis C virus were found in the hearts of 6 patients, and negative strands in the hearts of 2 patients.As a collaborative research project, a questionnaire was sent out to examine the possible association between hepatitis C virus infection and cardiomyopathies. Hepatitis C virus antibody was found in 74 of 697 patients (10.6%) with hypertrophic cardiomyopathy (mean age, 57.7 years) and in 42 of 663 patients (6.3%) with dilated cardiomyopathy (mean age, 56.5 years) ; these prevalences were significantly higher than that found in volunteer blood donors in Japan (2.4%, 50-59 years of age, each p<0.0001). The prevalence was significantly higher in patients suffering from hypertrophic cardiomyopathy as opposed to those with dilated cardiomyopathy (p<0.01). Presence of hepatitis virus antibody was detected in 650 of 11,967 patients (5.4%) seeking care in 5 academic hospitals. Various cardiac abnormalities were found among these patients with positive anti-hepatitis C virus antibody, arrhythmias being the most frequent. These observations suggest that hepatitis C virus infection is an important cause of a variety of otherwise unexplained heart diseases.
53例扩张型心肌病患者血清中有8例(15.1%)存在丙型肝炎病毒抗体,66例肥厚型心肌病患者血清中有11例(13.8%)存在丙型肝炎病毒抗体,而日本自愿献血者对照人群中有2.4%存在丙型肝炎病毒抗体,差异有统计学意义(p<0.0001)。在肥厚性心肌病中,9例患者中有5例血清中存在1b型丙型肝炎病毒RNA。丙型肝炎病毒拷贝数为5.5 × 10^3 ~ 8.6 × 10^5个基因组/ml血清,每个患者血清中均检测到丙型肝炎病毒的多个克隆。在6例患者心脏中发现丙型肝炎病毒阳性链,2例患者心脏中发现阴性链。作为一项合作研究项目,我们发出了一份调查问卷,以调查丙型肝炎病毒感染与心肌病之间可能存在的联系。697例肥厚型心肌病患者(平均年龄57.7岁)中74例(10.6%)和663例扩张型心肌病患者(平均年龄56.5岁)中42例(6.3%)检测到丙型肝炎病毒抗体;这些患病率明显高于日本的志愿献血者(2.4%,50-59岁,p<0.0001)。肥厚型心肌病患者的患病率明显高于扩张型心肌病患者(p<0.01)。在5所学术医院就诊的11,967名患者中,有650人(5.4%)检测出肝炎病毒抗体。丙型肝炎病毒抗体阳性的患者出现多种心脏异常,心律失常最为常见。这些观察结果表明,丙型肝炎病毒感染是各种其他无法解释的心脏病的重要原因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sasayama S,et al.: "Role of cytokines in the syndrome of heart failure" Int Med. 35. 60‐63 (1996)
Sasayama S 等人:“细胞因子在心力衰竭综合征中的作用”Int Med 35. 60‐63 (1996)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matsumori A.: "Cytokines in myocarditis and cardiomyopathies" Curr Op in Cardiol. 11. 302‐309 (1996)
Matsumori A.:“心肌炎和心肌病中的细胞因子”Curr Op in Cardiol。 11. 302‐309 (1996)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matsumori A,Yamada T,Matsui S,Shioi T,Sasayama S.: Cytokines and heart failure : Immunomodulating agents for the management of heart failure. In New Horizons for Failing Heart Syndrome, Edited by Sasayama S.Springer-Verlag, Tokyo, 219-232 (1996)
Matsumori A,Yamada T,Matsui S,Shioi T,Sasayama S.:细胞因子和心力衰竭:用于治疗心力衰竭的免疫调节剂。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Furukawa Y,et al.: "Immunomodulation by an adenylate cyclase activator,NKH477,in vivo and in vitro" Clin Immunol Immunopathol. 79. 25‐35 (1996)
Furukawa Y 等人:“体内和体外通过腺苷酸环化酶激活剂 NKH477 进行免疫调节”,《临床免疫病理学》79. 25-35 (1996)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shioi T,et al.: "Protective role of Interleukin-12 in viral myocarditis." J Mol Cell Cardiol. 29. 2327-2334 (1997)
Shioi T 等人:“Interleukin-12 在病毒性心肌炎中的保护作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATSUMORI Akira其他文献
MATSUMORI Akira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATSUMORI Akira', 18)}}的其他基金
International study on the prevalence of viral infection in myopcardial diseases
心肌疾病病毒感染流行率的国际研究
- 批准号:
18406029 - 财政年份:2006
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Roles of mast cells, stem cell factor and c-kit in heart failure
肥大细胞、干细胞因子和c-kit在心力衰竭中的作用
- 批准号:
16390223 - 财政年份:2004
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cytokine gene therapy of cardiovascular diseases by in vivo electroporation
体内电穿孔细胞因子基因治疗心血管疾病
- 批准号:
13557063 - 财政年份:2001
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of an animal model of cardiomyopathy by transfering hepatitis C virus genome.
通过转移丙型肝炎病毒基因组开发心肌病动物模型。
- 批准号:
11557050 - 财政年份:1999
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Pathogenesis of hypertrophic cardiomyopathy associated with hepatitis C virus.
与丙型肝炎病毒相关的肥厚型心肌病的发病机制。
- 批准号:
10470164 - 财政年份:1998
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on the pathogenesis of cardiomyopathy by quantitation of messenger RNA.
通过信使RNA定量研究心肌病的发病机制。
- 批准号:
04454263 - 财政年份:1992
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Development of diagnostic method to detect enterovirus by polymerase chain reaction
开发聚合酶链反应检测肠道病毒的诊断方法
- 批准号:
03557042 - 财政年份:1991
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
A study on autoimmune mechanism in the pathogenesis of myocarditis of cardiomyopathy analysis by anti-heart monoclonal antibody
抗心脏单克隆抗体分析心肌病心肌炎发病机制中的自身免疫机制
- 批准号:
02454255 - 财政年份:1990
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
MicroRNA-195在糖尿病性心肌病发生中的作用及其机理的探讨
- 批准号:81170204
- 批准年份:2011
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Decoding Dilated Cardiomyopathy in vitro: Linking Genetic Mutations to Phenotypic Dysfunction
体外解码扩张型心肌病:将基因突变与表型功能障碍联系起来
- 批准号:
495567 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Miscellaneous Programs
Evaluating sex specific differences in dilated cardiomyopathy
评估扩张型心肌病的性别特异性差异
- 批准号:
MR/W023830/1 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Fellowship
Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families (DCM Next)
促进扩张型心肌病患者和家庭的诊断、患者分层和治疗取得进展 (DCM Next)
- 批准号:
10085929 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
EU-Funded
Using miRNA to identify new therapeutic pathways for dilated cardiomyopathy
使用 miRNA 确定扩张型心肌病的新治疗途径
- 批准号:
10740082 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Dysregulated mechanosignaling in dilated cardiomyopathy caused by defective Filamin C
Filamin C 缺陷引起的扩张型心肌病的机械信号失调
- 批准号:
10877387 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Development of strategies to enhance titin (TTN) expression and treat dilated cardiomyopathy caused by TTN haploinsufficiency
开发增强肌联蛋白 (TTN) 表达并治疗 TTN 单倍体不足引起的扩张型心肌病的策略
- 批准号:
10662742 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Elucidation of pathogenesis mechanisms and exploration of therapeutic strategies using mouse models of dilated cardiomyopathy
扩张型心肌病小鼠模型阐明发病机制并探索治疗策略
- 批准号:
23K18221 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Discovery and Characterization of Rare Variant Effects in Dilated Cardiomyopathy via Large-Scale Biobank Analysis
通过大规模生物库分析发现和表征扩张型心肌病的罕见变异效应
- 批准号:
10682290 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Elucidation of Molecular Basis for Myocardial Fibrosis in Dilated Cardiomyopathy
扩张型心肌病心肌纤维化的分子基础阐明
- 批准号:
23K15174 - 财政年份:2023
- 资助金额:
$ 5.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




